search
Back to results

Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection

Primary Purpose

Infertility

Status
Terminated
Phase
Phase 2
Locations
United Kingdom
Study Type
Interventional
Intervention
Hydrosalpinx needle aspiration to arm 1
Sponsored by
Birmingham Women's NHS Foundation Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infertility focused on measuring Hydrosalpinx/IVF/Reproductive outcome., Hydrosalpinx

Eligibility Criteria

20 Years - 39 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • healthy women, ASA class 1 (normal healthy) or class 2 (with mild systemic disease);
  • undergoing IVF or ICSI and reaching the stage of egg collection;
  • with ultrasonically diagnosed hydrosalpinx and identifiable during the phase of ovarian stimulation;
  • giving written informed consent.

Exclusion Criteria:

  • patients not giving written informed consent;
  • patients cancelled for poor ovarian response;
  • ultrasonically diagnosed hydrosalpinx and identifiable for the first time at egg-collection

Sites / Locations

  • Assisted Conception Unit, Birmingham Women's Hospital, Birmingham University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

1

2

Arm Description

For those assigned to Group 1, the hydrosalpinx will be aspirated after all the eggs have been collected, under GA. Under ultrasound-guidance, the aspiration (egg collection) needle will be inserted into the hydrosalpinx and suction applied until no more fluid is obtained. If there are bilateral hydrosalpinges, the process is repeated on the opposite side.

Patients assigned to group 2 will not have the hydrosalpinx aspirated

Outcomes

Primary Outcome Measures

The primary outcome measures were biochemical (urinary hCG test performed 14 days after embryo transfer) and clinical (presence of gestational sac by transvaginal ultrasound scan) pregnancy rates per randomised women.

Secondary Outcome Measures

Secondary outcome measures were implantation rate, first trimester miscarriages (any pregnancy loss before 12 weeks gestation) and pelvic infection.

Full Information

First Posted
November 30, 2007
Last Updated
July 20, 2015
Sponsor
Birmingham Women's NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT00566956
Brief Title
Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection
Official Title
Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection Improves Pregnancy Outcome in In-vitro Fertilization: a Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2007
Overall Recruitment Status
Terminated
Why Stopped
The study was terminated because it is very difficult to recruit more patients.
Study Start Date
October 1999 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
June 2004 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Birmingham Women's NHS Foundation Trust

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
· What we know: Hydrosalpinx and IVF About 40% of patients undergoing IVF have tubal disease and in 25%-30% of tubal disease patients there is fluid collection within the tube; hydrosalpinx. The amount of fluid in the hydrosalpinx is known to increase with ovarian stimulation (as in IVF) and often empties into the uterine cavity. Fluid from hydrosalpinges has been found to be detrimental to the growth and development of mouse embryos in vitro, and associated with reduced levels of endometrial integrins in vivo. This could be the explanation of the reduced pregnancy rates after IVF in patients with tubal disease and hydrosalpinx compared with those with tubal disease but no hydrosalpinx. This effect was evidence in both fresh and frozen embryo transfer cycles. Also there was a significant increase in miscarriage in association with hydrosalpinx. The study aims to answer the question: does ultrasound-guided aspiration of ultrasound diagnosed hydrosalpinx at the time of egg collection improve the pregnancy rate in IVF?
Detailed Description
· What we do not know: Treatment of hydrosalpinx and IVF Several studies in the literature have suggested that the treatment of hydrosalpinx pre-IVF would improve the pregnancy rate to a level similar to tubal disease patients without hydrosalpinx. The treatment modalities explored were salpingectomy, salpingostomy, tubal occlusion and ultrasound-guided aspiration either one month before or at the time of egg collection. All studies reported to date have been retrospective and with poor control design. A prospective randomised controlled trial is needed. All modalities have been associated with a similar improvement in pregnancy rate, but the least invasive modality is ultrasound-guided aspiration at the time of oocyte collection. We propose to conduct a prospective randomised controlled trial to evaluate the effect of ultrasound-guided aspiration (versus no aspiration) of hydrosalpinx at the time of egg collection on the pregnancy rate in IVF.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility
Keywords
Hydrosalpinx/IVF/Reproductive outcome., Hydrosalpinx

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
66 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
For those assigned to Group 1, the hydrosalpinx will be aspirated after all the eggs have been collected, under GA. Under ultrasound-guidance, the aspiration (egg collection) needle will be inserted into the hydrosalpinx and suction applied until no more fluid is obtained. If there are bilateral hydrosalpinges, the process is repeated on the opposite side.
Arm Title
2
Arm Type
No Intervention
Arm Description
Patients assigned to group 2 will not have the hydrosalpinx aspirated
Intervention Type
Procedure
Intervention Name(s)
Hydrosalpinx needle aspiration to arm 1
Intervention Description
For those assigned to Group I, the hydrosalpinx will be aspirated after all the eggs have been collected, under GA. Under ultrasound-guidance, the aspiration (egg collection) needle will be inserted into the hydrosalpinx and suction applied until no more fluid is obtained. If there are bilateral hydrosalpinges, the process is repeated on the opposite side. The hydrosalpinx fluid is discarded
Primary Outcome Measure Information:
Title
The primary outcome measures were biochemical (urinary hCG test performed 14 days after embryo transfer) and clinical (presence of gestational sac by transvaginal ultrasound scan) pregnancy rates per randomised women.
Time Frame
2-4 weeks
Secondary Outcome Measure Information:
Title
Secondary outcome measures were implantation rate, first trimester miscarriages (any pregnancy loss before 12 weeks gestation) and pelvic infection.
Time Frame
2-4 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
39 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: healthy women, ASA class 1 (normal healthy) or class 2 (with mild systemic disease); undergoing IVF or ICSI and reaching the stage of egg collection; with ultrasonically diagnosed hydrosalpinx and identifiable during the phase of ovarian stimulation; giving written informed consent. Exclusion Criteria: patients not giving written informed consent; patients cancelled for poor ovarian response; ultrasonically diagnosed hydrosalpinx and identifiable for the first time at egg-collection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nahed Hammadieh, MD,MRCOG
Organizational Affiliation
Assisted Conception Unit
Official's Role
Principal Investigator
Facility Information:
Facility Name
Assisted Conception Unit, Birmingham Women's Hospital, Birmingham University
City
Birmingham
ZIP/Postal Code
B15 2TG
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
10548619
Citation
Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod. 1999 Nov;14(11):2762-9. doi: 10.1093/humrep/14.11.2762.
Results Reference
result
PubMed Identifier
18343810
Citation
Hammadieh N, Coomarasamy A, Ola B, Papaioannou S, Afnan M, Sharif K. Ultrasound-guided hydrosalpinx aspiration during oocyte collection improves pregnancy outcome in IVF: a randomized controlled trial. Hum Reprod. 2008 May;23(5):1113-7. doi: 10.1093/humrep/den071. Epub 2008 Mar 13.
Results Reference
derived

Learn more about this trial

Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection

We'll reach out to this number within 24 hrs